STEMCELL Technologies has raised $12.77M over 3 rounds. STEMCELL Technologies's latest funding round was a Line of Credit for on August 20, 2019. Date Round Amount Investors Valuation Revenue Sources 8/20/2019 Line of Credit Capital One $XXM 0 FY undefined 1 2/12/2018 Mezzanine $XXM Su...
Hydrocortisone Stock Solution is provided at a concentration of 96 µg/mL, which is ideal as a 200X stock solution for use with PneumaCult™-ALI (Catalog #05001), MammoCult™ (Catalog #05620), EpiCult™-B (Human; Catalog #05601), and EpiCult™-C (Catalog #05630) media. ...
CryoStor® CS10 is a uniquely formulated, serum-free, animal component-free and defined cryopreservation medium containing 10% dimethyl sulfoxide (DMSO). Designed to preserve cells in low temperature environments (-80 °C to -196 °C).
This obstacle can be overcome with new cell technologies, which allow stem cell in vitro expansion, while preserving their natural capacity for self-renewal and differentiation. Conclusion The animal studies discussed in this review agree that NSC/progenitor cell and MSC transplantation can be ...